Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Array Technologies Inc. ARRY

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, and Rest of the World with the United States deriving the majority of the revenue.


Recent & Breaking News (NDAQ:ARRY)

Oncothyreon and Array Announce Collaboration to Develop and Commercialize anti-HER2 Compound ARRY-380

PR Newswire May 30, 2013

Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting

PR Newswire May 15, 2013

Free Research Reports on ARRY, DTV, NLS and SNTS Issued by the Paragon Report

Marketwired May 8, 2013

Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference

PR Newswire May 8, 2013

Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013

PR Newswire May 6, 2013

Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer

PR Newswire May 6, 2013

Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013

PR Newswire April 29, 2013

Array BioPharma Inc. And GT Advanced Technologies Inc. Analysis Reports: (NASDAQ: ARRY), (NASDAQ: GTAT)

Accesswire April 23, 2013

Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop

PR Newswire April 4, 2013

Morning Research on Sanofi, Keryx Biopharma, VIVUS, and Array BioPharma

PR Newswire March 27, 2013

Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer

PR Newswire March 21, 2013

Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech's Industry Success

Marketwired March 14, 2013

Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology

PR Newswire March 5, 2013

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

Marketwired March 1, 2013

Array BioPharma To Present At The Cowen Annual Health Care Conference

PR Newswire February 26, 2013

Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013

PR Newswire February 4, 2013

Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013

PR Newswire January 29, 2013

Biotech Industry Expected to Experience More M&A Activity in 2013

Marketwired January 28, 2013

Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

PR Newswire December 27, 2012